HEPBEST 25 MG TABLETS

Get a Price/Quote

HEPBEST 25 MG TABLETS Specification

Pacakaging (Quantity Per Box)
30

Indication
HIV

Origin of Medicine
INDIA

Salt Composition
TENOFOVIR ALAFENAMIDE TABLETS 25 MG

Dosage Form
ONCE-A-DAY

Drug Type
Other

Ingredients
Tenofovir alafenamide (TAF) 25 mg tablets are an antiviral medication used to treat chronic Hepatitis B virus (HBV) infection. It is a more advanced version of tenofovir that is effective at a lower dose and is associated with a lower risk of side effects related to bone and kidney health. A common brand name for tenofovir alafenamide 25 mg is Vemlidy. Key features Active ingredient: Tenofovir alafenamide (TAF). Form: Film-coated tablet. Mechanism of action: As a prodrug, tenofovir alafenamide is converted in the body into its active form, tenofovir diphosphate. This active metabolite inhibits the viral enzyme (HBV polymerase) that is essential for viral replication, which reduces the amount of virus in the body. Dosage: Typically, one 25 mg tablet is taken orally once daily, usually with food to increase absorption. Appearance: Vemlidy tablets are yellow, round, and debossed with "GSI" on one side and "25" on the other. Therapeutic uses Chronic Hepatitis B (HBV): Tenofovir alafenamide is indicated for treating chronic HBV infection in adults and pediatric patients (typically ages 12 and older) with compensated liver disease. HIV-1 infection: TAF is also a component of several combination tablets used to treat HIV-1 infection, though it is not used alone for this purpose. Potential side effects The most frequently reported adverse reactions include: Headache Diarrhea Nausea Fatigue Abdominal pain Less common but more serious side effects may include lactic acidosis and severe liver problems. Important considerations Prescription only: Tenofovir alafenamide is a prescription medication and should only be taken under the supervision of a qualified healthcare provider. Drug interactions: TAF may interact with other medications, including certain antifungals, anticonvulsants, and other antivirals. Patient monitoring: Regular blood tests are required to monitor liver and kidney function during treatment. HBV transmission: Taking tenofovir alafenamide does not prevent the transmission of HBV to others through sexual contact or blood contamination. Precautions must continue to be used.

Physical Form
Tablets

Function
Other

Recommended For
Chronic hepatitis B virus

Dosage
ONCE-A-DAY

Dosage Guidelines
AS PER DIOCTOR ADVICE

Suitable For
Women, Adults, Aged Person

Quantity
1 Pieces

Storage Instructions
ROOM TEMPERATURE

HEPBEST 25 MG TABLETS Trade Information

Minimum Order Quantity
2 Pieces

FOB Port
NEW DELHI

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Supply Ability
500 Pieces Per Day

Delivery Time
3 Days

Sample Available
No

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
1*30

Main Export Market(s)
Asia

Main Domestic Market
All India

About HEPBEST 25 MG TABLETS

Tenofovir alafenamide (TAF) 25 mg tablets arean antiviral medication used to treat chronic Hepatitis B virus (HBV) infection. It is a more advanced version of tenofovir that is effective at a lower dose and is associated with a lower risk of side effects related to bone and kidney health. A common brand name for tenofovir alafenamide 25 mg is Vemlidy.

Key features

Active ingredient:Tenofovir alafenamide (TAF).
Form:Film-coated tablet.
Mechanism of action:As a prodrug, tenofovir alafenamide is converted in the body into its active form, tenofovir diphosphate. This active metabolite inhibits the viral enzyme (HBV polymerase) that is essential for viral replication, which reduces the amount of virus in the body.
Dosage:Typically, one 25 mg tablet is taken orally once daily, usually with food to increase absorption.
Appearance:Vemlidy tablets are yellow, round, and debossed with "GSI" on one side and "25" on the other.

Therapeutic uses

Chronic Hepatitis B (HBV):Tenofovir alafenamide is indicated for treating chronic HBV infection in adults and pediatric patients (typically ages 12 and older) with compensated liver disease.
HIV-1 infection:TAF is also a component of several combination tablets used to treat HIV-1 infection, though it is not used alone for this purpose.

Potential side effects

The most frequently reported adverse reactions include:

Headache
Diarrhea
Nausea
Fatigue
Abdominal pain

Less common but more serious side effects may include lactic acidosis and severe liver problems.

Important considerations

Prescription only:Tenofovir alafenamide is a prescription medication and should only be taken under the supervision of a qualified healthcare provider.
Drug interactions:TAF may interact with other medications, including certain antifungals, anticonvulsants, and other antivirals.
Patient monitoring:Regular blood tests are required to monitor liver and kidney function during treatment.
HBV transmission:Taking tenofovir alafenamide does not prevent the transmission of HBV to others through sexual contact or blood contamination. Precautions must continue to be used.